Human Gene ADIPOQ (ENST00000320741.7) from GENCODE V44
  Description: Homo sapiens adiponectin, C1Q and collagen domain containing (ADIPOQ), transcript variant 2, mRNA. (from RefSeq NM_004797)
RefSeq Summary (NM_004797): This gene is expressed in adipose tissue exclusively. It encodes a protein with similarity to collagens X and VIII and complement factor C1q. The encoded protein circulates in the plasma and is involved with metabolic and hormonal processes. Mutations in this gene are associated with adiponectin deficiency. Multiple alternatively spliced variants, encoding the same protein, have been identified. [provided by RefSeq, Apr 2010].
Gencode Transcript: ENST00000320741.7
Gencode Gene: ENSG00000181092.10
Transcript (Including UTRs)
   Position: hg38 chr3:186,842,710-186,858,463 Size: 15,754 Total Exon Count: 3 Strand: +
Coding Region
   Position: hg38 chr3:186,853,059-186,854,704 Size: 1,646 Coding Exon Count: 2 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
RNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther SpeciesGO Annotations
mRNA DescriptionsPathwaysOther NamesMethods
Data last updated at UCSC: 2023-08-18 00:09:47

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr3:186,842,710-186,858,463)mRNA (may differ from genome)Protein (244 aa)
Gene SorterGenome BrowserOther Species FASTAGene interactionsTable SchemaAlphaFold
BioGPSEnsemblEntrez GeneExonPrimerGencodeGeneCards
HGNCHPRDLynxMalacardsMGIneXtProt
OMIMPubMedReactomeUniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: ADIPO_HUMAN
DESCRIPTION: RecName: Full=Adiponectin; AltName: Full=30 kDa adipocyte complement-related protein; AltName: Full=Adipocyte complement-related 30 kDa protein; Short=ACRP30; AltName: Full=Adipocyte, C1q and collagen domain-containing protein; AltName: Full=Adipose most abundant gene transcript 1 protein; Short=apM-1; AltName: Full=Gelatin-binding protein; Flags: Precursor;
FUNCTION: Important adipokine involved in the control of fat metabolism and insulin sensitivity, with direct anti-diabetic, anti-atherogenic and anti-inflammatory activities. Stimulates AMPK phosphorylation and activation in the liver and the skeletal muscle, enhancing glucose utilization and fatty-acid combustion. Antagonizes TNF-alpha by negatively regulating its expression in various tissues such as liver and macrophages, and also by counteracting its effects. Inhibits endothelial NF-kappa-B signaling through a cAMP-dependent pathway. May play a role in cell growth, angiogenesis and tissue remodeling by binding and sequestering various growth factors with distinct binding affinities, depending on the type of complex, LMW, MMW or HMW.
SUBUNIT: Homomultimer. Forms trimers, hexamers and 12- to 18-mers. The trimers (low molecular weight complexes / LMW) are assembled via non-covalent interactions of the collagen-like domains in a triple helix and hydrophobic interactions within the globular C1q domain. Several trimers can associate to form disulfide-linked hexamers (middle molecular weight complexes / MMW) and larger complexes (higher molecular weight / HMW). The HMW-complex assembly may rely aditionally on lysine hydroxylation and glycosylation. LMW, MMW and HMW complexes bind to HBEGF, MMW and HMW complexes bind to PDGFB, and HMW complex binds to FGF2. Interacts with CTRP9A via the C1q domain (heterotrimeric complex) (By similarity).
SUBCELLULAR LOCATION: Secreted.
TISSUE SPECIFICITY: Synthesized exclusively by adipocytes and secreted into plasma.
DOMAIN: The C1q domain is commonly called the globular domain.
PTM: Hydroxylated Lys-33 was not identified in PubMed:16497731, probably due to poor representation of the N-terminal peptide in mass fingerprinting.
PTM: HMW complexes are more extensively glycosylated than smaller oligomers. Hydroxylation and glycosylation of the lysine residues within the collagene-like domain of adiponectin seem to be critically involved in regulating the formation and/or secretion of HMW complexes and consequently contribute to the insulin- sensitizing activity of adiponectin in hepatocytes (By similarity).
PTM: O-glycosylated. Not N-glycosylated. O-linked glycans on hydroxylysines consist of Glc-Gal disaccharides bound to the oxygen atom of post-translationally added hydroxyl groups. Sialylated to varying degrees depending on tissue. Thr-22 appears to be the major site of sialylation. Higher sialylation found in SGBS adipocytes than in HEK fibroblasts. Sialylation is not required neither for heterodimerization nor for secretion. Not sialylated on the glycosylated hydroxylysines. Desialylated forms are rapidly cleared from the circulation.
POLYMORPHISM: Genetic variations in ADIPOQ influence the variance in adiponectin serum levels and define the adiponectin serum levels quantitative trait locus 1 (ADIPQTL1) [MIM:612556].
DISEASE: Defects in ADIPOQ are the cause of adiponectin deficiency (ADPND) [MIM:612556]. ADPND results in very low concentrations of plasma adiponectin.
DISEASE: Genetic variations in ADIPOQ are associated with non- insulin-dependent diabetes mellitus (NIDDM) [MIM:125853]; also known as diabetes mellitus type 2. NIDDM is characterized by an autosomal dominant mode of inheritance, onset during adulthood and insulin resistance.
PHARMACEUTICAL: Adiponectin might be used in the treatment of diabetes type 2 and insulin resistance.
MISCELLANEOUS: Variants Arg-84 and Ser-90 show impaired formation of HMW complexes whereas variants Cys-112 and Thr-164 show impaired secretion of adiponectin in any form.
MISCELLANEOUS: HMW-complex blood contents are higher in females than in males, are increased in males by castration and decreased again upon subsequent testosterone treatment, which blocks HMW- complex secretion (By similarity). In type 2 diabetic patients, both the ratios of HMW to total adiponectin and the degree of adiponectin glycosylation are significantly decreased as compared with healthy controls.
SIMILARITY: Contains 1 C1q domain.
SIMILARITY: Contains 1 collagen-like domain.
WEB RESOURCE: Name=Wikipedia; Note=Adiponectin entry; URL="http://en.wikipedia.org/wiki/Adiponectin";

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: ADIPOQ
Diseases sorted by gene-association score: adiponectin deficiency* (874), fatty liver disease (31), acdc (28), glucose intolerance (24), acquired generalized lipodystrophy (19), prediabetes syndrome (16), gestational diabetes (15), obstructive sleep apnea (15), nonalcoholic steatohepatitis (13), idiopathic recurrent pericarditis (13), arteriosclerosis obliterans (13), liver disease (12), hyperglycemia (11), acanthosis nigricans (11), morbid obesity (11), arteriosclerosis (11), lipid metabolism disorder (10), arteriolosclerosis (10), hypertriglyceridemia (10), hypertensive retinopathy (10), glucose metabolism disease (10), sleep apnea (9), lipodystrophy (9), anorexia nervosa (9), acquired metabolic disease (9), vascular disease (8), nontuberculous mycobacterial lung disease (7), chronic pulmonary heart disease (7), overnutrition (7), obesity (7), abdominal obesity-metabolic syndrome 1 (6), diabetes mellitus, noninsulin-dependent (6), 3-hydroxyacyl-coa dehydrogenase deficiency (6), coronary artery disease (6), eating disorder (6), multiple symmetrical lipomatosis (6), severe pre-eclampsia (5), coronary artery aneurysm (5), endocrine pancreas disease (4), idiopathic edema (4), prader-willi syndrome (4), liver cirrhosis (4), diabetes mellitus, insulin-dependent (3), artery disease (3), heart disease (2), myocardial infarction (2), autoinflammation, lipodystrophy, and dermatosis syndrome (2), hutchinson-gilford progeria (2), inherited metabolic disorder (2), hypertension, essential (2), lipid storage disease (1)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 224.71 RPKM in Adipose - Subcutaneous
Total median expression: 544.82 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -13.2048-0.275 Picture PostScript Text
3' UTR -1037.983759-0.276 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR001073 - C1q
IPR008160 - Collagen
IPR008983 - Tumour_necrosis_fac-like

Pfam Domains:
PF00386 - C1q domain
PF01391 - Collagen triple helix repeat (20 copies)

Protein Data Bank (PDB) 3-D Structure
MuPIT help
4DOU - X-ray MuPIT


ModBase Predicted Comparative 3D Structure on Q15848
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
Genome BrowserGenome BrowserGenome BrowserNo orthologNo orthologNo ortholog
Gene Details     
Gene Sorter     
MGIRGDEnsembl   
Protein SequenceProtein SequenceProtein Sequence   
AlignmentAlignmentAlignment   

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0005102 receptor binding
GO:0005125 cytokine activity
GO:0005179 hormone activity
GO:0005515 protein binding
GO:0033691 sialic acid binding
GO:0042802 identical protein binding
GO:0042803 protein homodimerization activity

Biological Process:
GO:0001666 response to hypoxia
GO:0001934 positive regulation of protein phosphorylation
GO:0006006 glucose metabolic process
GO:0006091 generation of precursor metabolites and energy
GO:0006635 fatty acid beta-oxidation
GO:0007584 response to nutrient
GO:0007623 circadian rhythm
GO:0009744 response to sucrose
GO:0009749 response to glucose
GO:0009967 positive regulation of signal transduction
GO:0010469 regulation of receptor activity
GO:0010642 negative regulation of platelet-derived growth factor receptor signaling pathway
GO:0010739 positive regulation of protein kinase A signaling
GO:0010745 negative regulation of macrophage derived foam cell differentiation
GO:0010804 negative regulation of tumor necrosis factor-mediated signaling pathway
GO:0010875 positive regulation of cholesterol efflux
GO:0010906 regulation of glucose metabolic process
GO:0014823 response to activity
GO:0019395 fatty acid oxidation
GO:0030336 negative regulation of cell migration
GO:0030853 negative regulation of granulocyte differentiation
GO:0031667 response to nutrient levels
GO:0031953 negative regulation of protein autophosphorylation
GO:0032270 positive regulation of cellular protein metabolic process
GO:0032720 negative regulation of tumor necrosis factor production
GO:0032757 positive regulation of interleukin-8 production
GO:0032869 cellular response to insulin stimulus
GO:0033034 positive regulation of myeloid cell apoptotic process
GO:0034115 negative regulation of heterotypic cell-cell adhesion
GO:0034383 low-density lipoprotein particle clearance
GO:0034612 response to tumor necrosis factor
GO:0035690 cellular response to drug
GO:0042304 regulation of fatty acid biosynthetic process
GO:0042493 response to drug
GO:0042593 glucose homeostasis
GO:0043123 positive regulation of I-kappaB kinase/NF-kappaB signaling
GO:0043124 negative regulation of I-kappaB kinase/NF-kappaB signaling
GO:0043407 negative regulation of MAP kinase activity
GO:0045471 response to ethanol
GO:0045599 negative regulation of fat cell differentiation
GO:0045650 negative regulation of macrophage differentiation
GO:0045715 negative regulation of low-density lipoprotein particle receptor biosynthetic process
GO:0045721 negative regulation of gluconeogenesis
GO:0045776 negative regulation of blood pressure
GO:0045860 positive regulation of protein kinase activity
GO:0045892 negative regulation of transcription, DNA-templated
GO:0045923 positive regulation of fatty acid metabolic process
GO:0046326 positive regulation of glucose import
GO:0046888 negative regulation of hormone secretion
GO:0050728 negative regulation of inflammatory response
GO:0050731 positive regulation of peptidyl-tyrosine phosphorylation
GO:0050765 negative regulation of phagocytosis
GO:0050805 negative regulation of synaptic transmission
GO:0050873 brown fat cell differentiation
GO:0051260 protein homooligomerization
GO:0051384 response to glucocorticoid
GO:0070208 protein heterotrimerization
GO:0070373 negative regulation of ERK1 and ERK2 cascade
GO:0070543 response to linoleic acid
GO:0070994 detection of oxidative stress
GO:0071320 cellular response to cAMP
GO:0071639 positive regulation of monocyte chemotactic protein-1 production
GO:0071872 cellular response to epinephrine stimulus
GO:0072659 protein localization to plasma membrane
GO:0090317 negative regulation of intracellular protein transport
GO:1900121 negative regulation of receptor binding
GO:1904706 negative regulation of vascular smooth muscle cell proliferation
GO:1904753 negative regulation of vascular associated smooth muscle cell migration
GO:2000279 negative regulation of DNA biosynthetic process
GO:2000467 positive regulation of glycogen (starch) synthase activity
GO:2000478 positive regulation of metanephric glomerular visceral epithelial cell development
GO:2000481 positive regulation of cAMP-dependent protein kinase activity
GO:2000534 positive regulation of renal albumin absorption
GO:2000584 negative regulation of platelet-derived growth factor receptor-alpha signaling pathway
GO:2000590 negative regulation of metanephric mesenchymal cell migration

Cellular Component:
GO:0005576 extracellular region
GO:0005581 collagen trimer
GO:0005615 extracellular space
GO:0005783 endoplasmic reticulum
GO:0009986 cell surface
GO:0032991 macromolecular complex


-  Descriptions from all associated GenBank mRNAs
  JB406702 - Sequence 28 from Patent WO2012072685.
JB406703 - Sequence 29 from Patent WO2012072685.
AL832470 - Homo sapiens mRNA; cDNA DKFZp313G1421 (from clone DKFZp313G1421).
BC096308 - Homo sapiens adiponectin, C1Q and collagen domain containing, mRNA (cDNA clone MGC:116986 IMAGE:40007540), complete cds.
BC096309 - Homo sapiens adiponectin, C1Q and collagen domain containing, mRNA (cDNA clone MGC:116987 IMAGE:40007541), complete cds.
BC096310 - Homo sapiens adiponectin, C1Q and collagen domain containing, mRNA (cDNA clone MGC:116988 IMAGE:40007542), complete cds.
BC096311 - Homo sapiens adiponectin, C1Q and collagen domain containing, mRNA (cDNA clone MGC:116989 IMAGE:40007544), complete cds.
AK291525 - Homo sapiens cDNA FLJ78108 complete cds, highly similar to Homo sapiens adiponectin, C1Q and collagen domain containing (ADIPOQ), mRNA.
AK312868 - Homo sapiens cDNA, FLJ93312, highly similar to Homo sapiens adipose most abundant gene transcript 1 (APM1), mRNA.
AX767959 - Sequence 5 from Patent WO03044057.
D45371 - Homo sapiens apM1 mRNA for adipose specific collagen-like factor, complete cds.
BC054496 - Homo sapiens adiponectin, C1Q and collagen domain containing, mRNA (cDNA clone MGC:54246 IMAGE:6192794), complete cds.
JD515038 - Sequence 496062 from Patent EP1572962.
AB590676 - Synthetic construct DNA, clone: pFN21AE1740, Homo sapiens ADIPOQ gene for adiponectin, C1Q and collagen domain containing, without stop codon, in Flexi system.
KJ892758 - Synthetic construct Homo sapiens clone ccsbBroadEn_02152 ADIPOQ gene, encodes complete protein.
KR711809 - Synthetic construct Homo sapiens clone CCSBHm_00031129 ADIPOQ (ADIPOQ) mRNA, encodes complete protein.
KR711810 - Synthetic construct Homo sapiens clone CCSBHm_00031131 ADIPOQ (ADIPOQ) mRNA, encodes complete protein.
KR711811 - Synthetic construct Homo sapiens clone CCSBHm_00031132 ADIPOQ (ADIPOQ) mRNA, encodes complete protein.
KR711812 - Synthetic construct Homo sapiens clone CCSBHm_00031133 ADIPOQ (ADIPOQ) mRNA, encodes complete protein.
EU420013 - Homo sapiens adiponectin mRNA, complete cds.
JD386375 - Sequence 367399 from Patent EP1572962.
JD087803 - Sequence 68827 from Patent EP1572962.
JD443637 - Sequence 424661 from Patent EP1572962.
JD091170 - Sequence 72194 from Patent EP1572962.
JD271523 - Sequence 252547 from Patent EP1572962.
JD530994 - Sequence 512018 from Patent EP1572962.
JD386198 - Sequence 367222 from Patent EP1572962.
JD399337 - Sequence 380361 from Patent EP1572962.
JD152349 - Sequence 133373 from Patent EP1572962.
JD213340 - Sequence 194364 from Patent EP1572962.
JD463263 - Sequence 444287 from Patent EP1572962.
JD413814 - Sequence 394838 from Patent EP1572962.
JD247555 - Sequence 228579 from Patent EP1572962.
JD535469 - Sequence 516493 from Patent EP1572962.
JD193099 - Sequence 174123 from Patent EP1572962.
JD151439 - Sequence 132463 from Patent EP1572962.
JD426501 - Sequence 407525 from Patent EP1572962.
JD487356 - Sequence 468380 from Patent EP1572962.
JD070132 - Sequence 51156 from Patent EP1572962.
JD338546 - Sequence 319570 from Patent EP1572962.
JD364117 - Sequence 345141 from Patent EP1572962.
JD364118 - Sequence 345142 from Patent EP1572962.
JD242585 - Sequence 223609 from Patent EP1572962.
JD328728 - Sequence 309752 from Patent EP1572962.
JD490240 - Sequence 471264 from Patent EP1572962.
JD490241 - Sequence 471265 from Patent EP1572962.
JD480519 - Sequence 461543 from Patent EP1572962.
JD435501 - Sequence 416525 from Patent EP1572962.
JD227491 - Sequence 208515 from Patent EP1572962.
JD207072 - Sequence 188096 from Patent EP1572962.
JD364876 - Sequence 345900 from Patent EP1572962.
JD208328 - Sequence 189352 from Patent EP1572962.
JD369397 - Sequence 350421 from Patent EP1572962.
JD063408 - Sequence 44432 from Patent EP1572962.
JD114910 - Sequence 95934 from Patent EP1572962.
JD530666 - Sequence 511690 from Patent EP1572962.
JD471240 - Sequence 452264 from Patent EP1572962.
JD338917 - Sequence 319941 from Patent EP1572962.
JD219487 - Sequence 200511 from Patent EP1572962.
JD524829 - Sequence 505853 from Patent EP1572962.
JD284625 - Sequence 265649 from Patent EP1572962.
JD392316 - Sequence 373340 from Patent EP1572962.
JD133340 - Sequence 114364 from Patent EP1572962.
JD528127 - Sequence 509151 from Patent EP1572962.
JD353181 - Sequence 334205 from Patent EP1572962.
JD258885 - Sequence 239909 from Patent EP1572962.
JD256910 - Sequence 237934 from Patent EP1572962.
JD407924 - Sequence 388948 from Patent EP1572962.
JD480903 - Sequence 461927 from Patent EP1572962.
JD071887 - Sequence 52911 from Patent EP1572962.
JD470309 - Sequence 451333 from Patent EP1572962.
JD053900 - Sequence 34924 from Patent EP1572962.
JD359802 - Sequence 340826 from Patent EP1572962.
JD359801 - Sequence 340825 from Patent EP1572962.
JD242487 - Sequence 223511 from Patent EP1572962.
JD490117 - Sequence 471141 from Patent EP1572962.
JD446629 - Sequence 427653 from Patent EP1572962.
JD495803 - Sequence 476827 from Patent EP1572962.
JD175369 - Sequence 156393 from Patent EP1572962.
JD314263 - Sequence 295287 from Patent EP1572962.
JD328008 - Sequence 309032 from Patent EP1572962.
JD073319 - Sequence 54343 from Patent EP1572962.
JD564071 - Sequence 545095 from Patent EP1572962.
JD360955 - Sequence 341979 from Patent EP1572962.
JD300369 - Sequence 281393 from Patent EP1572962.
JD196744 - Sequence 177768 from Patent EP1572962.
JD355065 - Sequence 336089 from Patent EP1572962.
JD270664 - Sequence 251688 from Patent EP1572962.
JD490879 - Sequence 471903 from Patent EP1572962.
JD102389 - Sequence 83413 from Patent EP1572962.
JD181103 - Sequence 162127 from Patent EP1572962.
JD444879 - Sequence 425903 from Patent EP1572962.
JD081795 - Sequence 62819 from Patent EP1572962.
JD252289 - Sequence 233313 from Patent EP1572962.
JD527862 - Sequence 508886 from Patent EP1572962.
JD296065 - Sequence 277089 from Patent EP1572962.
JD227975 - Sequence 208999 from Patent EP1572962.
JD257886 - Sequence 238910 from Patent EP1572962.
JD409814 - Sequence 390838 from Patent EP1572962.
JD500950 - Sequence 481974 from Patent EP1572962.
JD291251 - Sequence 272275 from Patent EP1572962.
JD527957 - Sequence 508981 from Patent EP1572962.
JD162678 - Sequence 143702 from Patent EP1572962.
JD192846 - Sequence 173870 from Patent EP1572962.
JD192847 - Sequence 173871 from Patent EP1572962.
JD192848 - Sequence 173872 from Patent EP1572962.
JD087146 - Sequence 68170 from Patent EP1572962.
JD258293 - Sequence 239317 from Patent EP1572962.
JD107766 - Sequence 88790 from Patent EP1572962.
JD329810 - Sequence 310834 from Patent EP1572962.
JD360664 - Sequence 341688 from Patent EP1572962.
JD308191 - Sequence 289215 from Patent EP1572962.
JD356242 - Sequence 337266 from Patent EP1572962.
JD351036 - Sequence 332060 from Patent EP1572962.
JD566322 - Sequence 547346 from Patent EP1572962.
JD284236 - Sequence 265260 from Patent EP1572962.
JD298731 - Sequence 279755 from Patent EP1572962.
JD269073 - Sequence 250097 from Patent EP1572962.

-  Biochemical and Signaling Pathways
  KEGG - Kyoto Encyclopedia of Genes and Genomes
hsa03320 - PPAR signaling pathway
hsa04920 - Adipocytokine signaling pathway
hsa04930 - Type II diabetes mellitus

BioCarta from NCI Cancer Genome Anatomy Project
h_vobesityPathway - Visceral Fat Deposits and the Metabolic Syndrome

Reactome (by CSHL, EBI, and GO)

Protein Q15848 (Reactome details) participates in the following event(s):

R-HSA-8848663 ADIPOQ trimer binds ADIPOR dimers
R-HSA-381340 Transcriptional regulation of white adipocyte differentiation
R-HSA-163680 AMPK inhibits chREBP transcriptional activation activity
R-HSA-1266738 Developmental Biology
R-HSA-163685 Energy Metabolism
R-HSA-1430728 Metabolism

-  Other Names for This Gene
  Alternate Gene Symbols: ACDC, ACRP30, ADIPO_HUMAN, APM1, ENST00000320741.1, ENST00000320741.2, ENST00000320741.3, ENST00000320741.4, ENST00000320741.5, ENST00000320741.6, GBP28, NM_004797, Q15848, Q58EX9, uc003fra.1, uc003fra.2, uc003fra.3, uc003fra.4, uc003fra.5
UCSC ID: ENST00000320741.7
RefSeq Accession: NM_004797
Protein: Q15848 (aka ADIPO_HUMAN)
CCDS: CCDS3284.1

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.